FDA permits marketing of first US test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin. [electronic resource]
Producer: 20140630Description: i p. digitalISSN:- 1537-6591
- Antitubercular Agents -- pharmacology
- Bacteriological Techniques -- methods
- Drug Resistance, Bacterial
- Humans
- Mycobacterium tuberculosis -- drug effects
- Polymerase Chain Reaction
- Rifampin -- pharmacology
- Sputum -- microbiology
- Tuberculosis, Pulmonary -- microbiology
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.